...
首页> 外文期刊>Iranian Journal of Biotechnology >Implementation of Plasma Fractionation in Biological Medicines Production
【24h】

Implementation of Plasma Fractionation in Biological Medicines Production

机译:血浆分馏在生物药品生产中的实施

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Context:? The major motivation for the preparation of the plasma derived biological medicine was the treatment of casualties from the Second World War.? Due to the high expenses for preparation of plasma derived products, achievement of self-sufficiency in human plasma biotechnological industry is an important goal for developing countries.Evidence Acquisition:? The complexity of the blood plasma was first revealed by the Nobel Prize laureate, Arne Tiselius and Theodor Svedberg, which resulted in the identification of thousands of plasma proteins.? Among all these proteins, four of which are commercially important for production due to significant need of patients.? These four products are: albumin, IgG, factor VIII, and Factor IX.The starting material for the production of biological drugs from plasma is natural which is different from synthetic starting material. So, the quality of plasma as starting material plays an important role in the quality of final product. ?Introducing new techniques for preparation of the biological drugs from human plasma has resulted in the improvements in purity of products, higher safety, and yield noticeably. Still, the backbone of the modern plasma fractionation technique is mainly based on cold ethanol fractionation of the human plasma that is almost the same as fractionation of crude oil, breaking it down into its components.The demand for IgG for treating immune deficiencies and coagulation factor VIII for hemophilia A determines how to design the plasma fractionation industry in terms of capacity.Nowadays, cold ethanol fractionation has followed by chromatographic methods, since they offer higher purity.? In this review, we describe different methods of plasma fractionation such as cold ethanol fractionation, gel filtration, fractionation by salt, and fractionation by polyethylene glycol. There is no doubt that the four main products of human plasma are albumin, IgG, coagulation factor VIII, and IX, which their methods of separation from human plasma have been explained in this paper.Conclusions:? It can be concluded that plasma fractionation with ethanol at low temperature for the preparation of the main human plasma biological components including albumin, IgG, coagulation factors VIII, and IX is still the most widely used method at an industrial scale. Nowadays, this method is being used in combination with different chromatographic techniques in order to achieve a higher quality and the yield.
机译:上下文:?制备血浆衍生生物医学的主要动机是对第二次世界大战造成的伤亡的治疗。由于制备血浆衍生产品的高昂费用,实现人类血浆生物技术产业的自给自足是发展中国家的重要目标。血浆的复杂性首先由诺贝尔奖获得者Arne Tiselius和Theodor Svedberg揭示,从而鉴定出数千种血浆蛋白。在所有这些蛋白质中,由于患者的大量需求,其中四个对生产具有重要的商业意义。这四种产品是:白蛋白,IgG,VIII因子和IX因子。从血浆中生产生物药物的原料是天然的,这与合成原料不同。因此,等离子体作为原材料的质量在最终产品的质量中起着重要的作用。引入从人血浆中制备生物药物的新技术,已导致产品纯度,安全性和产率的显着提高。尽管如此,现代血浆分级分离技术的基础仍然是基于人体血浆的冷乙醇分级分离,这与原油的分级分离几乎相同,并将其分解成各种成分。对用于治疗免疫缺陷和凝血因子的IgG的需求血友病A VIII决定了如何根据容量设计血浆分馏行业。如今,由于冷乙醇分馏具有更高的纯度,因此其后采用了色谱方法。在这篇综述中,我们描述了血浆分馏的不同方法,例如冷乙醇分馏,凝胶过滤,盐分馏和聚乙二醇分馏。毫无疑问,人血浆的四个主要产物是白蛋白,IgG,凝血因子VIII和IX,它们在人血浆中的分离方法已经在本文中进行了解释。可以得出结论,在工业规模上,在低温下用乙醇进行血浆分馏以制备人的主要血浆生物成分包括白蛋白,IgG,凝血因子VIII和IX仍然是最广泛使用的方法。如今,此方法已与不同的色谱技术结合使用,以实现更高的质量和产量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号